The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

Sponsor
Ankara City Hospital Bilkent (Other)
Overall Status
Completed
CT.gov ID
NCT05997251
Collaborator
(none)
66
1
12
5.5

Study Details

Study Description

Brief Summary

The aim of this study is to reveal the relationship of DASH and Mediterranean diet score with anthropometric measurements and serum adiponectin level in individuals with spinal cord injury. This research was planned as a cross-sectional, case-control study. With the data to be obtained from the research, information will be obtained about the hormonal or biochemical basis of metabolic disorders such as atherosclerosis and insulin resistance that may occur in individuals with spinal cord injury in the long term.

20 individuals with Spinal Cord Injury will be included in the study, and the results of the patients will be compared with 20 healthy individuals. In order to determine the food consumption status of the patients, a 1-day food consumption record will be requested. DASH diet score and Mediterranean diet score will be calculated from dietary records. After 8 hours of fasting, 3 ml of peripheral blood will be taken for the measurement of adiponectin between 08:00 and 09:00 in the morning from the individuals in the study and control groups. Adiponectin level will be measured and its correlation with DASH diet score and Mediterranean diet score will be examined.

Condition or Disease Intervention/Treatment Phase
  • Other: Keeping a 1-day food consumption record by the patient
  • Other: Measurement of adiponectin level

Study Design

Study Type:
Observational
Actual Enrollment :
66 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Mar 1, 2022
Actual Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients with spinal cord injury

Other: Keeping a 1-day food consumption record by the patient
Checking and receiving the 1-day food consumption record recorded by the patient by the researcher

Other: Measurement of adiponectin level
Adiponectin level will be measured for each group

Healthy group

Other: Keeping a 1-day food consumption record by the patient
Checking and receiving the 1-day food consumption record recorded by the patient by the researcher

Other: Measurement of adiponectin level
Adiponectin level will be measured for each group

Outcome Measures

Primary Outcome Measures

  1. Adiponectin level [Will be measured at inclusion]

    Adiponectin level will be measured from peripheral blood

  2. DASH diet score [Will be measured at inclusion from one day dietary record]

    Will be measured at inclusion from one day dietary record

  3. Mediterrenian diet score [Will be measured at inclusion from one day dietary record]

    Will be measured at inclusion from one day dietary record

Secondary Outcome Measures

  1. Whole blood count [Will be measured at inclusion]

    Will be measured at inclusion

  2. Fasting blood glucose [Will be measured at inclusion]

    Will be measured at inclusion

  3. Total cholesterol [Will be measured at inclusion]

    Will be measured at inclusion

  4. LDL [Will be measured at inclusion]

    Will be measured at inclusion

  5. HDL [Will be measured at inclusion]

    Will be measured at inclusion

  6. TG [Will be measured at inclusion]

    Will be measured at inclusion

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Inclusion criteria (Study group)

  • Having spent at least 6 months after spinal cord injury

  • 1st motor neuron injury

  • Being between the ages of 18-65

  • Giving consent to participate in the study Inclusion criteria (Control group)

  • Being between the ages of 18-65

  • Giving consent to participate in the study

Exclusion Criteria:
  • Exclusion criteria (Study group)

  • Having an additional disease to the spinal cord injury

  • Having a 2nd motor neuron lesion

Exclusion criteria (Control group)

• Having any disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara Bilkent City Hospital Physical Treatment and Rehabilitation Hospital Ankara Turkey

Sponsors and Collaborators

  • Ankara City Hospital Bilkent

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Emre Adıgüzel, MD, Ankara City Hospital Bilkent
ClinicalTrials.gov Identifier:
NCT05997251
Other Study ID Numbers:
  • E2-21-89
First Posted:
Aug 18, 2023
Last Update Posted:
Aug 18, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Emre Adıgüzel, MD, Ankara City Hospital Bilkent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2023